Mammographyscreenings lower breast cancer-related deaths by approximately 30%.
### New Study Highlights Importance of Mammography Screening in Reducing Breast Cancer Mortality in Germany
Recent research has shed light on the impact of mammography screening on breast cancer outcomes in Germany. The study, published in Berlin, involved data from research institutions, cancer registries, and several health insurance companies. The research project evaluated mammography screening data from 2009 to 2018 for women aged 50 to 69, and expanded the eligibility for mammography screening to include women up to the age of 75.
The study found that mammography screening can reduce breast cancer mortality by up to 30 percent. This is particularly significant for women aged 50 and over, who are more susceptible to breast cancer. The study also showed for the first time in Germany that mammography screening can significantly reduce mortality.
Although the study did not mention any changes in the survival rate or death rate from breast cancer in Germany, early detection of breast cancer improves healing chances and thus the survival rate. The study did not provide information on the breast cancer diagnosis rate among women aged 70 to 75, but it is known that women up to the age of 75 now have a claim to an X-ray examination of the breast.
It is important to note that around 75,000 women receive a breast cancer diagnosis each year in Germany, making it the most common cancer-related cause of death among women in the country. Around 18,500 women die from breast cancer in Germany each year.
The study's findings underscore the importance of mammography screening in reducing breast cancer mortality. Combining mammography with other screening techniques can achieve a 73% gain in mortality reduction compared to mammography alone, often at similar or moderately increased costs.
The ongoing efforts to improve breast cancer care are evident in events such as the ESMO Breast Cancer 2025 event in Munich, Germany, which will focus on the latest advancements in breast cancer diagnosis, treatment, and survivorship. Such events highlight the continued importance of breast cancer research and the role of screening in managing the disease.
In conclusion, while specific current mortality rates are not provided, mammography screening plays a crucial role in reducing breast cancer mortality in Germany, and ongoing research and events like ESMO Breast Cancer 2025 are pivotal in advancing breast cancer care.
- The study, published in Berlin, shows that mammography screening can significantly reduce breast cancer mortality by up to 30 percent for women aged 50 and over, who are more susceptible to the disease.
- The research also emphasizes that combining mammography with other screening techniques can achieve a 73% gain in mortality reduction compared to mammography alone, often at similar or moderately increased costs.
- The findings of the study emphasize the importance of medical-conditions screening, such as mammography, in women's health and health-and-wellness, especially in the context of science and fighting against cancer.
